CNNMoney.com
Companies Economy International Corrections Pre-market trading After-hours trading Winners/losers/actives Bonds Currencies Commodities Money Magazine Retirement Mutual Funds Taxes Ask the Expert Money 101 Autos Loan Center Best Places to Live Calculators Mortgage Rates Personal tech Big Tech blog Techland blog Sectors and stocks Fortune 500 techs Tech Talk 100 best places to launch Ultimate resource guide Small biz makeovers FSB 100 Fortune 500 Technology Investing Management Rankings Main Create portfolio Edit portfolio Create Alerts Edit Alerts

Diet pill marketers hit with false ad fines

Companies agree to pay Federal Trade Commission $25M iafter products failed to live up to promises of weight loss or weight control.


NEW YORK (CNNMoney.com) -- The Federal Trade Commission said Thursday it fined marketers of such popular over-the-counter diet drugs as Xenadrine EFX and TrimSpa millions of dollars for using false advertising practices.

The government agency, which settled the claims for $25 million, said that the pills that made weight loss and weight control claims were not supported by scientific evidence.

As part of the the settlement, the government said the marketers promised to limit future advertising claims.

"You won't find weight loss in a bottle of pills that claims it has the latest scientific breakthrough or miracle ingredient," FTC Chairman Deborah Platt Majoras said in a prepared statement. "Paying for fad science is a good way to lose cash, not pounds."

Besides Xenadrine EFX and TrimSpa, the FTC said it also settled false advertising claims with the marketers of CortiSlim and Bayer AG's (down $0.17 to $54.11, Charts) One-A-Day WeightSmart.


Big Pharma trounces Biotech in 2006  Top of page

© 2008 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy
Copyright © 2008 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. All Times are ET.
Intraday data provided by ComStock, an Interactive Data Company and subject to the Terms of Use.
Historical, current end-of-day data, and splits data provided by FT Interactive Data.
Fundamental data provided by Hemscott.
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.
* : Time reflects local markets trading time.† - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges.• Disclaimer